H-CYTE, INC.

H-CYTE, INC. insiders are currently net buyers of HCYT stock, showing bullish sentiment over the past 90 days. Executives have purchased $8.2K while selling $0, resulting in a positive net flow of $8.2K. This buying activity represents 100% of total transaction volume.

H-CYTE, INC. has 5 active insiders who have filed SEC Form 4 transactions in the past 90 days. J. Rex Farrior III (Executive) leads with 2 transactions totaling $6.4M. William E. Horne (Executive) follows with 2 transactions worth $1.7M. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.

The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. H-CYTE, INC.'s current score of 100/100 indicates bullish insider sentiment. Scores above 60 suggest insiders are accumulating shares faster than selling, reflecting $8.2K in purchases versus $0 in sales.

The most recent insider transaction occurred on Mar 21, 2022, when J. Lynch Frederick (Executive) disposed of 8,321,785 shares at $0.00 per share for $0. This appears to be a discretionary trade.

Based on SEC Form 4 filings from the past 90 days, HCYT insider trading sentiment is currently bullish with an Alignment Score of 100/100. The net insider flow of $8.2K reflects accumulation, with 100% of volume being purchases.

SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like H-CYTE, INC.. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At HCYT, we track all Form 4 filings—currently showing 16 transactions from 5 insiders over 90 days.

A 10b5-1 plan allows H-CYTE, INC. executives to pre-schedule stock sales when they don't possess material non-public information. At HCYT, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at HCYT appears discretionary, making insider signals more meaningful.

You can monitor H-CYTE, INC. (HCYT) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 5 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.

Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. H-CYTE, INC.'s current score of 100/100 indicates strong bullish sentiment with executives accumulating shares. This is calculated from $8.2K in purchases versus $0 in sales over 90 days, resulting in a net flow of $8.2K.

SEC Form 4 filings are mandatory reports that H-CYTE, INC. insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At HCYT, the most common type is "P" with 6 occurrences. The most recent Form 4 was filed on Mar 21, 2022 by J. Lynch Frederick.

Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At H-CYTE, INC., approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at HCYT represents discretionary decisions with more informational value.